Magenta Therapeutics, Inc.·4

May 19, 4:23 PM ET

GARDNER JASON 4

4 · Magenta Therapeutics, Inc. · Filed May 19, 2022

Insider Transaction Report

Form 4
Period: 2022-05-17
GARDNER JASON
DirectorSee Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-17+162,500162,500 total
    Exercise: $1.18Exp: 2032-05-16Common Stock (162,500 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in three equal installments, each installment vesting every six months, over the 18 months following the vesting commencement date. The vesting commencement date is May 15, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION